SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology & Drugs
An SI Board Since February 2001
Posts SubjectMarks Bans
232 7 0
Emcee:  2MAR$ Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
57Have to look up the last report on GENZ, I think they warned ....but after every2MAR$-3/6/2002
56I have option straddle on GENZ...did it on MOnday... VRTS interesting spot...chSusieQ1065-3/6/2002
55GENZ ($44 ) reporting tomorrow, IMCL($28.50) deal with Bristol seeing restoring 2MAR$-3/6/2002
54Biotech Hopes Grow, Leaving Less Room for Failure By Toni Clarke NEW YORK (Reut2MAR$-12/29/2001
53IMCL says FDA refuses cancer-drug application By Ransdell Pierson NEW YORK, De2MAR$-12/29/2001
52Hopefully not too O/T for this thread: Very recent news, in the Biological thertwentyfirstcenturyfox-12/12/2001
51Everything you wanted to know about: <b> " Application of Biochip Mi2MAR$-11/22/2001
50Worthwhile post on biotechs from Gorilla Thread : Message 16673390 <<<2MAR$-11/22/2001
49Amgen Expects Accelerated Growth in 2002 Financial Performance Total Product Sa2MAR$-11/22/2001
48CEPH ( $61-$68)Reports Q3 (Sep) earnings of $0.40 per share, $0.34 better than t2MAR$-11/6/2001
47BGEN ($56-53-55) says revenue to double by '05 "but" forecasts pro2MAR$-11/4/2001
46AFFX ( $22-$32-$30) eps =-1.21 cap=1.7bil posts smaller than expected third-qua2MAR$-11/4/2001
45PDLI ( $34 -$36-$34) PE=whatever Cap=$3Bil third-quarter loss narrows stockchar2MAR$-11/4/2001
44DNA ($40-$45) P/E 234 $22Bil/cap third-quarter earnings rise 22 pct By Deena B2MAR$-10/12/2001
43<b><font color=fuchsia> ******** NEW QTR START ********2MAR$-10/12/2001
42Scientists, companies clash over research (Embargoed for release 6:30 p.m. EDT2MAR$-9/9/2001
41More Specifically on "Anticipating" AMGN news: ARTHRITIS ADVISORY COMWayners-8/13/2001
40Just some notes on MEDX, MEDI, HGSI, AMGN .... bunny girl ;-) MEDAREX (MEDX, $2MAR$-8/10/2001
39Some Biotech Notes.... 1. COMMENTARY The tremendous lack of trading volume i2MAR$-8/10/2001
38MEDX ($21-$19) <b>P/E 135 </b>..Beats by 5 Cents...Rev's rose 16SusieQ1065-8/7/2001
37CEPH ($66-$61) Beats Q2 Estimates, Warns for Q3 New York, Aug 07, 2001 (123Jump2MAR$-8/7/2001
36AVIR ( $24-$23) second-quarter net loss widens MOUNTAIN VIEW, Calif., Aug. 2 (Re2MAR$-8/2/2001
35PDLI ( $56-$48) falls after Q2 report By Lisa Sanders, CBS.MarketWatch.com Las2MAR$-8/2/2001
34NOVN ( $34-$24) Noven Pharmaceuticals warns of lower 2001 profits biz.yahoo.com 2MAR$-8/2/2001
33CELG ($27-29-27)Announces Second Quarter Results WARREN, N.J., July 26 /PRNewsw2MAR$-7/28/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News